Ricardo González-Ramírez

Dr. Ricardo González-Ramírez

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MOMiguel Ortíz-Rentería
Miguel Ortíz-Rentería
RJRebeca Juárez-Contreras
Rebeca Juárez-Contreras
RGRicardo González-Ramírez
Ricardo González-Ramírez
LILeon Islas
Leon Islas
FSFélix Sierra-Ramírez
Félix Sierra-Ramírez
SMSara Luz Morales-Lázaro
Sara Luz Morales-Lázaro
Significance: The TRPV1 ion channel has been widely associated with the generation of painful responses. The responses of cells expressing this ion channel and, presumably, the overall pain response of an organism may be regulated by controlling the amount of TRPV1 channels in the plasma membrane. TRPV1 levels can be regulated by its interaction with intracellular proteins, but there are no studies describing TRPV1 or any other mammalian TRP channel’s association with chaperones or how these interactions may affect the perception of pain. Here, we show that TRPV1-dependent pain is decreased through Sig-1R antagonism by progesterone and determine the presence of a physical interaction between these two proteins that may reduce pain under physiological conditions such as pregnancy.

1 October 2006 in Experimental Cell Research
Verified
Journal Article
Closed access
LFLizeth Fuentes
Lizeth Fuentes
Rafael Rodríguez-MuñozRafael Rodríguez-Muñoz
Rafael Rodríguez-Muñoz
RGRicardo González-Ramírez
Ricardo González-Ramírez
FGFrancisco García-Sierra
Francisco García-Sierra
EREverardo Gonzalez Rodriguez
Everardo Gonzalez Rodriguez
BCBulmaro Cisneros
Bulmaro Cisneros

24 April 2019 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
SMSara Luz Morales-Lázaro
Sara Luz Morales-Lázaro
RGRicardo González-Ramírez
Ricardo González-Ramírez
TRTamara Rosenbaum
Tamara Rosenbaum
Cell excitability is tightly regulated by the activity of ion channels that allow for the passage of ions across cell membranes. Ion channel activity is controlled by different mechanisms that change their gating properties, expression or abundance in the cell membrane. The latter can be achieved by forming complexes with a diversity of proteins like chaperones such as the Sigma-1 receptor (Sig-1R), which is one with unique features and exhibits a role as a ligand-operated chaperone. This molecule also displays high intracellular mobility according to its activation level since, depletion of internal Ca+2 stores or the presence of specific ligands, produce Sig-1R’s mobilization from the endoplasmic reticulum toward the plasma membrane or nuclear envelope. The function of the Sig-1R as a chaperone is regulated by synthetic and endogenous ligands, with some of these compounds being a steroids and acting as key endogenous modifiers of the actions of the Sig-1R. There are cases in the literature that exemplify the close relationship between the actions of steroids on the Sig-1R and the resulting negative or positive effects on ion channel function/abundance. Such interactions have been shown to importantly influence the physiology of mammalian cells leading to changes in their excitability. The present review focuses on describing how the Sig-1R regulates the functional properties and the expression of some sodium, calcium, potassium, and TRP ion channels in the presence of steroids and the physiological consequences of these interplays at the cellular level are also discussed.

4 August 2008 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
RGRicardo González-Ramírez
Ricardo González-Ramírez
SMS.L. Morales‐Lázaro
S.L. Morales‐Lázaro
VTV. Tapia‐Ramírez
V. Tapia‐Ramírez
DMD. Mornet
D. Mornet
BVBulmaro Cisneros Vega
Bulmaro Cisneros Vega

15 April 2013 in Stem Cells and Development
Verified
Journal Article
Closed access
MLMargarita Leyva-Leyva
Margarita Leyva-Leyva
LBLourdes Barrera
Lourdes Barrera
César López-CamarilloCésar López-Camarillo
César López-Camarillo
LALourdes Andrea Arriaga-Pizano
Lourdes Andrea Arriaga-Pizano
GOGabriel Orozco-Hoyuela
Gabriel Orozco-Hoyuela
LFLizeth Fuentes
Lizeth Fuentes
Human fetal mesenchymal stem cells can be isolated from the amniotic membrane (AM-hMSCs) by enzymatic digestion. The biological properties of this cell population have been characterized; however, few studies have focused on the presence of stem cell subpopulations and their differentiation potential. The aim of the present study was to isolate homogeneous AM-hMSC subpopulations based on the coexpression of surface markers. In addition, we aimed to characterize stem cell subpopulations through the detection of typical stem cell markers and its differentiation potential. In this study, fluorescence-activated cell sorting (FACS) was used to positively select for the surface markers CD44, CD73, and CD105. Two subpopulations were isolated: CD44+/CD73+/CD105+ (CD105+), and CD44+/CD73+/CD105− (CD105−). To characterize the cell subpopulations, the expression of pluripotency-associated markers was analyzed by reverse transcriptase–polymerase chain reaction and immunofluorescence. Our results showed positive expression of SOX2, SOX3, PAX6, OCT3/4, and NANOG in the CD105+ and CD105− cell subpopulations. In contrast, we did not detect expression of SSEA4 or FOXD3 in either subpopulation. Immunophenotypes, such as mesenchymal and hematopoietic markers, were studied by FACS analyses. Our data revealed the expression of the CD49a, CD49d, CD29, integrin α9β1, CD44, CD73, and CD105 antigens in both subpopulations. In contrast, CD90, CD45, CD34, CD14, and HLA-DR expression was not detected. The ability of both subpopulations to differentiate into osteoblasts, adipocytes, and chondrocytes was evidenced using Alizarin red, Oil-Red, and Alcian blue staining, respectively. Furthermore, neuronal differentiation was demonstrated by the expression of GFAP and NEURO-D. Interestingly, we observed a dissimilar osteoblastic differentiation potential between the subpopulations. CD105− cells showed stronger expression of secreted protein acidic and rich in cysteine (SPARC) and osteonectin, which was associated with more effective calcium deposition, than CD105+ cells. In conclusion, we described a systematic method for the isolation of hMSCs that was highly reproducible and generated homogeneous cultures for osteoblast differentiation with an efficient capacity for mineralization.

1 March 2016 in Pain
Verified
Journal Article
Closed access
MBMariana Bravo-Hernández
Mariana Bravo-Hernández
JCJosé A. Corleto
José A. Corleto
PBPaulino Barragán-Iglesias
Paulino Barragán-Iglesias
RGRicardo González-Ramírez
Ricardo González-Ramírez
JPJorge B. Pineda-Farias
Jorge B. Pineda-Farias
VGVinicio Granados-Soto
Vinicio Granados-Soto
It has been recently proposed that α5-subunit containing GABAA receptors (α5-GABAA receptors) that mediate tonic inhibition might be involved in pain. The purpose of this study was to investigate the contribution of α5-GABAA receptors in the loss of GABAergic inhibition and in formalin-induced, complete Freund's adjuvant (CFA)-induced and L5 and L6 spinal nerve ligation-induced long-lasting hypersensitivity. Formalin or CFA injection and L5 and L6 spinal nerve ligation produced long-lasting allodynia and hyperalgesia. Moreover, formalin injection impaired the rate-dependent depression of the Hofmann reflex. Peripheral and intrathecal pretreatment or post-treatment with the α5-GABAA receptor antagonist, L-655,708 (0.15-15 nmol), prevented and reversed, respectively, these long-lasting behaviors. Formalin injection increased α5-GABAA receptor mRNA expression in the spinal cord and dorsal root ganglia (DRG) mainly at 3 days. The α5-GABAA receptors were localized in the dorsal spinal cord and DRG colabeling with NeuN, CGRP, and IB4 which suggests their presence in peptidergic and nonpeptidergic neurons. These receptors were found mainly in small and medium sized neurons. Formalin injection enhanced α5-GABAA receptor fluorescence intensity in spinal cord and DRG at 3 and 6 days. Intrathecal administration of L-655,708 (15 nmol) prevented and reversed formalin-induced impairment of rate-dependent depression. These results suggest that α5-GABAA receptors play a role in the loss of GABAergic inhibition and contribute to long-lasting secondary allodynia and hyperalgesia.